BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The South Africa Trade Desk - ECPv6.16.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.satradedesk.com
X-WR-CALDESC:Events for The South Africa Trade Desk
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260617T110000
DTEND;TZID=UTC:20260617T133000
DTSTAMP:20260613T093116Z
CREATED:20260613T093116Z
LAST-MODIFIED:20260613T093116Z
UID:2988-1781694000-1781703000@www.satradedesk.com
SUMMARY:Development Dialogue: The Socio-economic realities of localising pharmaceutical production
DESCRIPTION:Following the COVID-19 pandemic\, South Africa became a linchpin in the push to strengthen health security for the African continent by expanding the local pharmaceuticals industry. The complexity of the global pharmaceutical value chain\, however\, makes for a nuancedstory where the balance between policy and economic reality is critical to decisions made across government sectors. \nTIPS explored the economic arguments for government support of localisation as part of a GIZ-funded project for dtic and DSTI. Thestudy examines the practicalities of government support for pharmaceutical production in South Africa\, with a case study on expanding vaccine manufacturing. It addresses the central question of how to align the push for local manufacturing with the mandate and needs ofthe public health system. \nThis dialogue is an opportunity to engage with the nuances of the research for different government and business stakeholders\, looking towards how South Africa can use the resources it does have to actively promote a key manufacturing sector while ensuring health security for the country and the continent. \nAgenda \n11h00 – 11h10 Welcome and opening remarks: Dr Saul Levin (TIPS) \n11h10 – 12h30 Presentations and Discussion \nDr Neva Makgetla (TIPS) – Socio-economic effects of localising parts of the pharmaceutical industry \nSakhile Ndlovu (TIPS) – Assessing the feasibility of scaling local vaccine manufacturing in South Africa \nAnnie Parsons (TIPS) – Future vaccine financing considerations \nSwasthie Soomaroo (the dtic)andMarione Schonfeldt (NDoH) – Discussant 12h30 – 12h55 Discussion \n12h55 – 13h00 Closure \nSpeaker biographies \nDr Saul Levin is the Executive Director of Trade and Industrial Policy Strategies (TIPS). Prior to that Saul worked at a senior level in severalgovernment departments\, including the Departments of Trade and Industry; Minerals and Energy; and Water and Forestry. He has alsoworked at Standard Bank\, and at a government agency supporting enterprise development. Saul has PhD in Development Studies from theUniversity of Johannesburg. \nNeva Makgetla is a senior economist at TIPS with extensive experience in research and national economic policy in South Africa. Shepreviously served as Deputy Director-General for economic policy and held senior roles at the Development Bank of Southern Africa\, thePresidency\, and COSATU. She holds a PhD in Economics and has a long academic and policy career. \nSakhile Ndlovu is an economist and researcher at TIPS\, working on industrial policy for inclusive and sustainable development in SouthAfrica. His work spans a range of projects on inclusive industrialisation and industrial development\, including contributions topharmaceutical and cosmetics policy\, local vaccine manufacturing\, and manufacturing subsector analysis. \nAnnie Parsons is a researcher at TIPS with a focus on health systems\, working with the GIZ-funded SAVax project. Her focus builds onexperiences from health system strengthening projects with the National Department of Health. \nMarione Schonfeldt is the Senior Pharmaceutical Policy Specialist for the National Department of Health’s Health Products Procurementdirectorate. She holds a Masters in Pharmacy management and public health and has worked at both national and provincial level healthdepartments. \nSwasthi Soomaroo is Director of Pharmaceuticals and Medical Devices at the dtic. She previously served as the Director of AdvancedManufacturing at the dtic. \nEnquiries: Bongeka@tips.org.za
URL:https://www.satradedesk.com/event/development-dialogue-the-socio-economic-realities-of-localising-pharmaceutical-production/
LOCATION:Illovo
CATEGORIES:Healthcare,In Person,Manufacturing,Pharmaceutical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260708T193000
DTEND;TZID=UTC:20260708T193000
DTSTAMP:20260629T110129Z
CREATED:20260629T110000Z
LAST-MODIFIED:20260629T110129Z
UID:3088-1783539000-1783539000@www.satradedesk.com
SUMMARY:South African Businesses in Africa: The Integration Imperative
DESCRIPTION:Can South Africa maintain its position as Africa’s leading business and industrial hub in the face of rising competition from across the continent and beyond? \nDespite its sophisticated economy\, deep financial markets and world-class corporate expertise\, South Africa’s advantage can no longer be taken for granted. Sustained growth will depent increasingly on deeper African integration. \nJoin us for the second edition of the Africa Dialogue Series as we explore how South Africa’s trade and investment footprint across Africa is evolving\, the value it is creating for both South Africa and its partners\, and where the next wave of opportunity lies in an increasingly competiive landscape. \nDate:Wednesday\, 8 July 2026 \nTime: 5:30pm for 6pm to 7:30pm followed by light refreshments \nVenue: Classroom 2\, GIBS\, 26 Melville Road\, Illovo \nCost: Members – complimentary | Non-members – R150
URL:https://www.satradedesk.com/event/south-african-businesses-in-africa-the-integration-imperative/
LOCATION:GIBS – Illovo\, 6 Melville Road\, Illovo\, South Africa
CATEGORIES:In Person
END:VEVENT
END:VCALENDAR